Sonia Anchouche

Sonia Anchouche

Auto-generated profile, based on publicly available information

Sonia Anchouche

Laboratory of Corneal Immunology, Transplantation and Regeneration, Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA; Faculty of Medicine, McGill University, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2021 in The Ocular Surface
Verified
Journal Article
Closed access
Rohan Bir SinghRohan Bir Singh
Rohan Bir Singh
LLLingjia Liu
Lingjia Liu
SASonia Anchouche
Sonia Anchouche
AYAnn Yung
Ann Yung
SMSharad K. Mittal
Sharad K. Mittal
RDReza Dana
Reza Dana

23 July 2020 in Cornea
Verified
Journal Article
Closed access
SASonia Anchouche
Sonia Anchouche
MHMona Harissi-Dagher
Mona Harissi-Dagher
LSLaura Segal
Laura Segal
LRLouis Racine
Louis Racine
MDMahshad Md Darvish-Zargar
Mahshad Md Darvish-Zargar
MRMarie-Claude Robert
Marie-Claude Robert
Purpose: To examine the outcomes of cyanoacrylate tissue adhesive (CTA) application for impending or frank corneal perforations and assess for predictors of treatment response. Methods: A multicenter cohort study was conducted to assess the clinical outcomes of adult patients who underwent CTA gluing for impending or frank corneal perforations between 2013 and 2018. The primary outcome was the proportion of successful CTA applications, defined as tectonic stability of the globe without subsequent keratoplasty (KP). Secondary outcomes included visual acuity and success of subsequent surgical interventions, if performed. Results: Fifty-three eyes of 52 patients were included in this study [56% women; mean age at presentation 70 ± 13 years; median length of follow-up of 387 days (interquartile range: 191–704)]. Medical comorbidities were present in 62% of patients. The most common etiologies for perforations included infections (43%) and Sjogren disease (9%). Of the CTA-treated eyes, 22% had a complete resolution of the corneal lesion. Fifty-four percent of patients underwent KP. Longer duration of CTA treatment was associated with CTA success (P = 0.04). For patients requiring KP, 71% were successful and 29% failed. There is no significant difference in the median time delay between patients with successful and failed KPs (P = 0.4). Conclusions: CTA may be considered a stand-alone treatment for corneal perforations. It yielded a success rate of 22%. Failed CTA treatment occurred quickly, largely because of the severity of presentation. In cases requiring KP, the delay between glue application and surgery did not influence the PK success.

1 July 2021 in The Ocular Surface
Verified
Journal Article
Closed access
SASonia Anchouche
Sonia Anchouche
NHNathan Hall
Nathan Hall
SBSila Bal
Sila Bal
RDReza Dana
Reza Dana
TETobias Elze
Tobias Elze
JYJia Yin
Jia Yin

15 May 2021 in The Ocular Surface
Verified
Journal Article
Closed access
Rohan Bir SinghRohan Bir Singh
Rohan Bir Singh
LLLingjia Liu
Lingjia Liu
AYAnn Yung
Ann Yung
SASonia Anchouche
Sonia Anchouche
SMSharad K. Mittal
Sharad K. Mittal
RDReza Dana
Reza Dana

29 December 2019 in Clinical & Investigative Medicine
Verified
Journal Article
Open access
PDF file
SASonia Anchouche
Sonia Anchouche
JLJiaru Liu
Jiaru Liu
SVSara Vucetic
Sara Vucetic
KSKim Santerre
Kim Santerre
TZTianwei E. Zhou
Tianwei E. Zhou
The Vision Health Research Network (VHRN) is a provincial scientific organization that aims to improve the ocular health of patients across Quebec by supporting local research endeavors in vision health. The VHRN Student Committee, composed of 288 trainees with diverse backgrounds, has demonstrated its commitment to the scholarly development of its members by providing leadership opportunities, creating networking events, increasing visibility of researchers-in-training and encouraging professional advancement through educational workshops and funding programs. In this article, we review the contributions of the VHRN Student Committee and discuss its future projects.

8 April 2026 in Ophthalmic Plastic & Reconstructive Surgery
Verified
Journal Article
Closed access
SASonia Anchouche
Sonia Anchouche
KCKenneth Chang
Kenneth Chang
MAMohammad Altibi
Mohammad Altibi
BDBrendan C. Dickson
Brendan C. Dickson
PMPascal J. Mosimann
Pascal J. Mosimann
DDDan D. DeAngelis
Dan D. DeAngelis
This case report describes a rare presentation of orbital cellular myofibroma in a 30-year-old female who initially presented with right proptosis and conjunctival injection. Endovascular embolization followed by surgical resection revealed an unencapsulated, vascular tumor with histopathologic and molecular findings consistent with cellular myofibroma harboring an SRF::RELA gene fusion. This case highlights the diagnostic challenges associated with orbital tumors and the importance of considering myofibroma in the differential diagnosis. The report also underscores the role of multidisciplinary management in optimizing outcomes for patients with rare orbital neoplasms.